Malignant pleural mesothelioma is a notoriously difficult form of cancer to treat. The aggressive, asbestos-related disease is always considered fatal, with most patients succumbing to their illness within a year of diagnosis. However, the Froedtert & the Medical College of Wisconsin health network recently reported good results after treating a patient with immunotherapy drugs.
Mesothelioma is one of the most challenging forms of cancer to treat. The aggressive disease has proven resistant to traditional protocols and is always considered fatal. This week a study reveals a new way to combat therapy-resistant cancers, and mesothelioma researchers are hoping that it can be applied to the rare and deadly asbestos-related malignancy.
The Peter MacCallum Cancer Center is a renowned cancer treatment center that has been a leader in mesothelioma research. Located in Melbourne, Australia, the facility affectionately referred to as “Peter Mac” is credited with several breakthroughs in cancer treatment, including having discovered the “Hippo” signaling pathway that holds promise for a better understanding of the
Pulmonologists are physicians with deep knowledge of the respiratory system, and they are often the specialists that primary care physicians turn to when their patients are experiencing pleural effusion and other mesothelioma symptoms. Pulmonologists’ expertise in lung function plays an important role in including mesothelioma in the patient’s differential diagnosis, as well as in managing
Virginia Cancer Specialists offers a complete spectrum of care for patients with pleural mesothelioma and lung cancer. Based in Fairfax, Virginia, the organization provides patients with state-of-the-art treatment options in a convenient location. Patients also have unique access to research and clinical trials.
West Cancer Center & Research Institute is a comprehensive cancer center located in Memphis, Tennessee. Its physicians and researchers are dedicated to the delivery of cutting-edge, compassionate cancer care for patients diagnosed with cancers of all types, including malignant peritoneal and pleural mesothelioma and lung cancer.
Massachusetts General Cancer Center in Boston, Massachusetts. It is a leading cancer center recognized for patient care and research, including its care of those diagnosed with thoracic cancers like lung cancer and malignant pleural mesothelioma.
Tufts Medical Center Cancer Center is at the forefront of the diagnosis and treatment of malignant mesothelioma and lung cancer. Located in Boston, Massachusetts, Tufts is also a leader in innovative research.
Cardinal Bernardin Cancer Center is a leader in the treatment of malignant pleural mesothelioma and lung cancer. The facility uses a multidisciplinary approach highlighted by skilled thoracic surgeons.
Georgia Cancer Center in Augusta, Georgia is a leader in cancer research and the treatment of patients diagnosed with malignant pleural mesothelioma and lung cancer. The facility’s thoracic disease department offers expert, innovative care.